Table 1.
n | % | |
---|---|---|
Gender | ||
Female | 22 | 56.4 |
Male | 17 | 43.6 |
Age (years) | ||
Median (range) | 56 (28–65) | |
28–42 years | 5 | 12.8 |
43–65 years | 34 | 87.2 |
Weight (kg), median (range) | 76.0 (42.9–115.0) | |
Height (cm), median (range) | 169.0 (149.0–187.0) | |
BSA (m2), median (range) | 1.9 (1.4–2.3) | |
Heart rate (bpm), median (range) | 76 (56-103) | |
Systolic blood pressure (mmHg), median (range) | 123 (93–147) | |
Diastolic blood pressure (mmHg), median (range) | 74 (56–86) | |
Body temperature (ºC), median (range) | 36.6 (35.0–37.3) | |
ECOG PS | ||
0 | 17 | 43.6 |
1 | 22 | 56.4 |
ECG | ||
Normal | 29 | 74.4 |
Non-significant abnormalities | 10 | 25.6 |
LVEF, median (range) | ||
ECHO (n = 35) | 62.0 (50.0–75.0) | |
MUGA (n = 4) | 65.5 (56.0–67.0) | |
Tumor type | ||
Endometrial carcinoma | 9 | 23.1 |
Head and neck carcinoma | 6 | 15.4 |
Neuroendocrine tumors | 5 | 12.8 |
Small cell lung cancer | 5 | 12.8 |
Biliary tract carcinoma | 4 | 10.3 |
Ewing’s family of tumors | 3 | 7.7 |
Germ cell tumor | 3 | 7.7 |
BRCA 1/2-associated metastatic breast carcinoma | 2 | 5.1 |
Carcinoma of unknown primary site | 2 | 5.1 |
bpm beats per minute, BSA body surface area, ECG electrocardiogram, ECHO echocardiography, ECOG PS Eastern Cooperative Oncology group performance status, LVEF left-ventricular ejection fraction, MUGA multiple-gated acquisition scan